Latest papers

Preparation of novel ferrocene-based shell cross-linked thermoresponsive hybrid micelles with antitumor efficacy.

Parallel synthesis of a series of non-functional ATP/NAD analogs with activity against trypanosomatid parasites.

Molecular diversity of volatile compounds in rare willow (Salix spp.) honeydew honey: identification of chemical biomarkers.

Simultaneous determination of four marker components in Yukmijihwang Tang by high performance liquid chromatography/diode array detector.

Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes.

[Microbiological transformation of paeoniflorin and albiflorin].

Ability of deferasirox to bind iron during measurement of iron.

Novel approaches for myelodysplastic syndromes: beyond hypomethylating agents.

[RRLC-UV-MS fingerprint of Radix Astragali]

The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis.

[PPARgamma antagonist as a potential drug for the treatment of obesity and diabetes]

Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers.

Eltrombopag. Idiopathic thrombocytopenic purpura after treatment failure: romiplostim is a better option.

Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells.

HJV hemochromatosis, iron overload, and hypogonadism in a Brazilian man: treatment with phlebotomy and deferasirox.

Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.

Deferasirox treatment interruption in a transfusion-requiring myelodysplastic patient led to loss of erythroid response.

Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.

Population pharmacokinetics and pharmacodynamics of cinaciguat, a soluble guanylate cyclase activator, in patients with acute decompensated heart failure.

[Diamond-Blackfan anemia. Case report].